المصدر:instname:Universidad del Rosario; reponame:Repositorio Institucional EdocUR; Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet [Internet]. 2010 Sep 25 [cited 2014 Jul 16];376(9746):1094–108. Available from:; Gremese E, Salaffi F, Bosello SL, Ciapetti A, Bobbio-Pallavicini F, Caporali R, et al. Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study. Ann Rheum Dis [Internet]. 2013 Jun;72(6):858–62. Available from:; Soderlin MK, Petersson IF, Bergman S, Svensson B. Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: experiences from BARFOT, a long-term observational study on early RA. Scand J Rheumatol. 2011;40(4):249–55.; Balsa A. [Defining remission in Rheumatoid Arthritis. New ACR/EULAR criteria]. Reumatol Clin [Internet]. 2011 Mar 1 [cited 2016 May 20];6S3(Notice: Undefined index: numeroInicial in /var/; Pincus T, Sokka T. Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care. Best Pract Res Clin Rheumatol. 2003 Oct;17(5):753–81.; Bird P, Nicholls D, Barrett R, de Jager J, Griffiths H, Roberts L, et al. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study. Int J Rheum Dis [Internet]. 2017 Apr;20(4):460–8. Available from:; Euesden J, Matcham F, Hotopf M, Steer S, Cope AP, Lewis CM, et al. The Relationship Between Mental Health, Disease Severity, and Genetic Risk for Depression in Early Rheumatoid Arthritis. Psychosom Med. 2017;79(6):638–45; Curtis JR, McVie T, Mikuls TR, Reynolds RJ, Navarro-Millan I, O’Dell J, et al. Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial. J Rheumatol. 2013 May;40(5):572–8; MH M, F I, D W, A H, EH C, PD K, et al. Remission in early rheumatoid arthritis: predicting treatment response. In: Journal of rheumatology [Internet]. Canada; 2012. p. 470–5. Available from:; T. R, J. A, P. H, T. Y-K, P. E, L. P, et al. Three out of every four patients with DMARD-naive early rheumatoid arthritis meet DAS28 remission at 12 months in Finland. Ann Rheum Dis [Internet]. 2016;75:697–8. Available from:; M.C. G, I. B, F. C, S. F, C. I, G. C, et al. Hypovitaminosis D predicts more aggressive evolution and lower response to treatment in early rheumatoid arthritis after 12 months of follow-up. Ann Rheum Dis [Internet]. 2013;72. Available from:; Arnold MB, Bykerk VP, Boire G, Haraoui BP, Hitchon C, Thorne C, et al. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort. Rheumatology (Oxford). 2014 Jun;53(6):1075–86.; Kuriya B, Xiong J, Boire G, Haraoui B, Hitchon C, Pope J, et al. Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis - Results from the Canadian Early Arthritis Cohort (CATCH). J Rheumatol. 2014;41(11):2161–6.; Schulman E, Bartlett SJ, Schieir O, Andersen KM, Boire G, Pope JE, et al. Overweight and Obesity Reduce the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort Study. Arthritis Care Res (Hoboken) [Internet]. :n/a-n/a. Available from:; Sandberg MEC, Bengtsson C, Kallberg H, Wesley A, Klareskog L, Alfredsson L, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2014 Nov;73(11):2029–33.; Quintana-Duque MA, Caminos JE, Varela-Narino A, Calvo-Paramo E, Yunis JJ, Iglesias-Gamarra A. The Role of 25-Hydroxyvitamin D as a Predictor of Clinical and Radiological Outcomes in Early Onset Rheumatoid Arthritis. J Clin Rheumatol. 2017 Jan;23(1):33–9; Quintana-Duque MA, Rondon-Herrera F, Mantilla RD, Calvo-Paramo E, Yunis JJ, Varela-Narino A, et al. Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study. Clin Rheumatol. 2016 Jun;35(6):1463–73; Steunebrink LMM, Versteeg GA, Vonkeman HE, Ten Klooster PM, Kuper HH, Zijlstra TR, et al. Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry. Arthritis Res Ther. 2016 Mar;18:60.; Kuijper TM, Luime JJ, de Jong PHP, Gerards AH, van Zeben D, Tchetverikov I, et al. Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial. Ann Rheum Dis. 2016 Dec;75(12):2119–23.; Contreras-Yanez I, Pascual-Ramos V. Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters. Arthritis Res Ther. 2015 Jul;17:177
Processing Request
No Comments.